Benitec Biopharma Inc. (BNTC) Q2 2024 Annual Earnings
BNTC·Reported September 26, 2024·Before market open
Diluted EPS came in at $-1.32, missed the $-0.49 consensus by $0.83.
Diluted EPS
$-1.32missed by $0.83
Consensus: $-0.49
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Benitec Biopharma Inc.'s Q2 2024 earnings report.
Benitec Biopharma Inc. (BNTC) reported Q2 2024 earnings on September 26, 2024 before market open.
Benitec Biopharma Inc. reported diluted EPS of $-1.32 for Q2 2024.
EPS missed the consensus estimate of $-0.49 by $0.83.
You can read the 10-K periodic report (0001193125-24-226968) directly on SEC EDGAR. The filing index links above go to sec.gov.